“Surgery Following Induction (Neoadjuvant) Therapy with Pembrolizumab in Lung Adenocarcinoma with High PD-L1 Expression”, Respirar, vol. 17, no. 1, pp. 68–75, Oct. 2025, doi: 10.55720/respirar.17.1.6.